Recent studies have increasingly reported abnormal ITGA2 expression across a range of malignancies, including gastric, pancreatic, breast, liver cancers, and glioma, where it plays a crucial role in various aspects of tumor initiation and progression [26]. Here, ITGA2 is linked to liver cancer.